A New York Post report on September 15 covers a study tying a popular brain supplement, commonly sold for memory and focus, to shorter lifespan specifically in men who took it regularly. The design is observational: researchers tracked supplement use in a cohort over years and compared death rates between users and non-users, which means the study can show an association but cannot, on its own, prove the supplement caused the earlier deaths. That distinction matters here because supplement users are rarely a random slice of the population. People who reach for a brain pill often do so because they're already worried about cognitive decline, a marker itself tied to underlying cardiovascular or metabolic disease, so the pill can end up correlated with death without being anywhere near the cause.

This is the same trap that has caught nearly every mass-market supplement claim of the last two decades, from vitamin E to beta-carotene: a plausible mechanism, a worried population that self-selects into taking it, and a headline that outruns the study design. None of that means the finding is nothing. An association between a product taken by millions and higher mortality in a specific sex is worth a randomized trial to sort correlation from cause, and until one exists, the honest read is that this pill has not been shown to protect the brain it's marketed to help, and now carries an open question about harm that its manufacturers have not answered with trial data.